Literature DB >> 25088797

AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.

Zong-Cai Liu1, Hong-Sheng Wang1, Ge Zhang1, Hao Liu2, Xiao-Hui Chen1, Fan Zhang1, Dan-Yang Chen1, Shao-Hui Cai3, Jun Du4.   

Abstract

BACKGROUND: Epithelial-mesenchymal transition (EMT) plays a pivotal role in the development of metastatic cancers. Basic fibroblast growth factor (bFGF) is significantly elevated in metastatic prostate cancers, which has been mentioned mainly to induce EMT in normal cells. However, there is no description about bFGF induced EMT and its underlying mechanism in prostate cancer cells.
METHODS: Western blotting, immunofluorescence and qRT-PCR assays were used to study protein or mRNA expression profiles of the EMT. Wound healing scratch, migration and invasion assays were used to test the motility of cells undergoing EMT. More methods were used to explore the underlying mechanisms.
RESULTS: We demonstrated that bFGF promoted EMT and motility of human prostate cancer PC-3 cells. Both protein and mRNA expression of Snail were rapidly increased after bFGF treatment. Ectopic expression of Snail triggered EMT and enhanced cell motility in PC-3 cells, and knockdown of Snail almost abolished bFGF induced EMT, suggesting the critical role of Snail. Mechanistic study demonstrated that bFGF promoted the stability, nuclear localization and transcription of Snail by inhibiting the activity of glycogen synthase kinase 3 beta (GSK-3β) through phosphatidylinositide 3 kinases (PI3K)/protein kinase B (AKT) signaling pathway.
CONCLUSIONS: It is concluded that bFGF can promote EMT and motility of PC-3 cells, and AKT/GSK-3β signaling pathway controls the stability, localization and transcription of Snail which is crucial for this bFGF induced EMT. GENERAL SIGNIFICANCE: To our knowledge, this is the first study to demonstrate that bFGF can induce EMT via AKT/GSK-3β/Snail signaling pathway in prostate cancer cells.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Basic fibroblast growth factor; Epithelial–mesenchymal transition; Invasion; Prostate cancer; Snail

Mesh:

Substances:

Year:  2014        PMID: 25088797     DOI: 10.1016/j.bbagen.2014.07.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.

Authors:  Lei Fan; Wulan Li; Shilong Ying; Lingyi Shi; Zhe Wang; Gaozhi Chen; Hui Ye; Xiaoping Wu; Jianzhang Wu; Guang Liang; Xiaokun Li
Journal:  Tumour Biol       Date:  2015-04-19

2.  Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.

Authors:  Osamu Maehara; Goki Suda; Mitsuteru Natsuizaka; Shunsuke Ohnishi; Yoshito Komatsu; Fumiyuki Sato; Masato Nakai; Takuya Sho; Kenichi Morikawa; Koji Ogawa; Tomoe Shimazaki; Megumi Kimura; Ayaka Asano; Yoshiyuki Fujimoto; Shinya Ohashi; Shingo Kagawa; Hideaki Kinugasa; Seiji Naganuma; Kelly A Whelan; Hiroshi Nakagawa; Koji Nakagawa; Hiroshi Takeda; Naoya Sakamoto
Journal:  Carcinogenesis       Date:  2017-10-26       Impact factor: 4.944

3.  Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis.

Authors:  Jianchao Zhang; Xinxin Lin; Liufeng Wu; Jia-Jia Huang; Wen-Qi Jiang; Thomas J Kipps; Suping Zhang
Journal:  Oncogene       Date:  2020-01-29       Impact factor: 9.867

Review 4.  Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.

Authors:  Lili Zhou; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

5.  CCR7 pathway induces epithelial-mesenchymal transition through up-regulation of Snail signaling in gastric cancer.

Authors:  Jianping Zhang; Yunzhe Zhou; Yonggang Yang
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

6.  Overexpression of histone demethylase JMJD5 promotes metastasis and indicates a poor prognosis in breast cancer.

Authors:  Zhihua Zhao; Chuntao Sun; Fengqi Li; Jiankui Han; Xanjun Li; Zhenguo Song
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models.

Authors:  Giovanni Luca Gravina; Andrea Mancini; Luca Scarsella; Alessandro Colapietro; Ana Jitariuc; Flora Vitale; Francesco Marampon; Enrico Ricevuto; Claudio Festuccia
Journal:  Tumour Biol       Date:  2015-07-29

8.  Epac1 deficiency inhibits basic fibroblast growth factor-mediated vascular smooth muscle cell migration.

Authors:  Yuko Kato; Utako Yokoyama; Takayuki Fujita; Masanari Umemura; Tetsuo Kubota; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2018-08-06       Impact factor: 2.781

9.  Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway.

Authors:  Fang Fang; Shuang Chen; Jing Ma; Jiabo Cui; Qiang Li; Guixian Meng; Liguo Wang
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

10.  Aberrant GSK3β nuclear localization promotes AML growth and drug resistance.

Authors:  James J Ignatz-Hoover; Victoria Wang; Nathan M Mackowski; Anne J Roe; Isaac K Ghansah; Masumi Ueda; Hillard M Lazarus; Marcos de Lima; Elisabeth Paietta; Hugo Fernandez; Larry Cripe; Martin Tallman; David N Wald
Journal:  Blood Adv       Date:  2018-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.